These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2375883)

  • 1. Inhibition of beta-glucuronidase in human urine by ascorbic acid.
    Young JC; Kenyon EM; Calabrese EJ
    Hum Exp Toxicol; 1990 May; 9(3):165-70. PubMed ID: 2375883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ascorbic acid on urine pH in patients with injured spinal cords.
    Hetey SK; Kleinberg ML; Parker WD; Johnson EW
    Am J Hosp Pharm; 1980 Feb; 37(2):235-7. PubMed ID: 7361797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of urinary pH through ascorbic acid].
    Bannwart C; Hagmaier V; Straumann E; Hofer H; Vuillemier JP; Rutishauser G
    Helv Chir Acta; 1981 Aug; 48(3-4):425-8. PubMed ID: 7287481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ascorbic acid on calcium elimination in humans.
    Tsao CS; Miyashita K; Leung PY
    J Nutr Sci Vitaminol (Tokyo); 1986 Aug; 32(4):437-46. PubMed ID: 3806257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase.
    Matsuo E; Skinsnes OK; Chang PH
    Int J Lepr Other Mycobact Dis; 1975; 43(1):1-13. PubMed ID: 1099016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of urinary beta-glucuronidase activity. Single-point versus enzyme kinetic measuring system.
    Ho KJ; Ho LH
    Enzyme; 1980; 25(6):361-70. PubMed ID: 7202386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma.
    Tecklenburg SL; Mickleborough TD; Fly AD; Bai Y; Stager JM
    Respir Med; 2007 Aug; 101(8):1770-8. PubMed ID: 17412579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of glucuronidase by ascorbic acid and by heparin.
    BECKER B; FRIEDENWALD JS
    Arch Biochem; 1949 May; 22(1):101-7. PubMed ID: 18126566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interactions between desoxycholic acid glucuronides and glucuronidase (author's transl)].
    Oehlke J
    Pharmazie; 1980; 35(10):629-34. PubMed ID: 7454746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficacy of ascorbic acid as a urinary acidifier.
    Mc Leod DC; Nahata MC
    N Engl J Med; 1977 Jun; 296(24):1413. PubMed ID: 16214
    [No Abstract]   [Full Text] [Related]  

  • 11. Appraisal of ascorbic acid for acidifying the urine of methenamine-treated geriatric patients.
    Naccarto DV; Bell CJ; Lamy PP
    J Am Geriatr Soc; 1979 Jan; 27(1):34-7. PubMed ID: 32196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of megavitamin therapy on children with attention deficit disorders.
    Haslam RH; Dalby JT; Rademaker AW
    Pediatrics; 1984 Jul; 74(1):103-11. PubMed ID: 6234505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of tobacco smoking on albumin concentration and β-glucuronidase activity in urine of smelters].
    Bizonń A; Witt K; Milnerowicz M; Milnerowicz H
    Przegl Lek; 2014; 71(11):581-4. PubMed ID: 25799848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffectiveness of intravenous ascorbic acid as an acidifying agent in man.
    Barton CH; Sterling ML; Thomas R; Vaziri ND; Byrne C; Ryan G
    Arch Intern Med; 1981 Feb; 141(2):211-2. PubMed ID: 7458517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.
    Burns J; Ouvrier RA; Yiu EM; Joseph PD; Kornberg AJ; Fahey MC; Ryan MM
    Lancet Neurol; 2009 Jun; 8(6):537-44. PubMed ID: 19427269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective determination of catechin, epicatechin and ascorbic acid in human urine using chiral capillary electrophoresis.
    el-Hady DA; Gotti R; el-Maali NA
    J Sep Sci; 2008 Jul; 31(12):2252-9. PubMed ID: 18546394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial.
    Micallef J; Attarian S; Dubourg O; Gonnaud PM; Hogrel JY; Stojkovic T; Bernard R; Jouve E; Pitel S; Vacherot F; Remec JF; Jomir L; Azabou E; Al-Moussawi M; Lefebvre MN; Attolini L; Yaici S; Tanesse D; Fontes M; Pouget J; Blin O
    Lancet Neurol; 2009 Dec; 8(12):1103-10. PubMed ID: 19818690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of rebound effect with ascorbic acid.
    Tsao CS; Salimi SL
    Med Hypotheses; 1984 Mar; 13(3):303-10. PubMed ID: 6717321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Different urine parameters in healthy human subjects during intake of 4 g L(+)-ascorbic acid].
    Hanck AB
    Int J Vitam Nutr Res; 1974; 44(3):302-8. PubMed ID: 4459284
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Applephenon and ascorbic acid on physical fatigue.
    Ataka S; Tanaka M; Nozaki S; Mizuma H; Mizuno K; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y
    Nutrition; 2007 May; 23(5):419-23. PubMed ID: 17483009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.